+499.5%
MRNA vs ENTG
+76.2%
+423.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ENTG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +6.2% | -8.4% | -2.6% |
| 7D | +5.5% | +2.8% | +2.6% | +5.3% |
| 30D | +158.7% | -4.7% | +163.4% | +157.7% |
| 3M | +182.1% | -0.7% | +182.9% | +164.8% |
| 6M | +151.8% | +7.7% | +144.1% | +126.2% |
| YTD | +393.6% | +65.1% | +328.5% | +295.5% |
| 1Y | +499.5% | +74.8% | +424.7% | +337.9% |
| All | +499.5% | +76.2% | +423.3% | +337.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ENTG.
Daily Out/Under-Performance
Portfolio return minus ENTG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENTG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ENTG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling